Meeting report of the 2014 joint international congress of the International Liver Transplantation Society, Liver Intensive Care Group of Europe, and European Liver and Intestinal Association-Reference-Cited by-同舟云学术

Meeting report of the 2014 joint international congress of the International Liver Transplantation Society, Liver Intensive Care Group of Europe, and European Liver and Intestinal Association

Published:2015-06-26 Issue:7 Volume:21 Page:991-1000
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Diaz Geraldine¹,Levitsky Josh²,Oniscu Gabriel³

Affiliation:

1. Department of Anesthesia and Critical Care; University of Chicago; Chicago IL

2. Department of Gastroenterology and Comprehensive Transplant Center, Feinberg School of Medicine; Northwestern University; Chicago IL

3. Scottish Liver Transplant Unit; Royal Infirmary of Edinburgh; Edinburgh United Kingdom

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.24144/fullpdf

Reference81 articles.

1. Sofosbuvir and ribavirin for the treatment of chronic HCV with cirrhosis and portal hypertension with and without decompensation: early virologic response and safety;Afdhal;Liver Transpl,2014

2. Sofosbuvir plus ribavirin before transplantation prevented HCV infection post-transplant in patients with HCV cirrhosis and HCC: results of an open-label trial;Curry;Liver Transpl,2014

3. Sofosbuvir and ribavirin for the treatment of recurrent hepatitis C infection after liver transplantation: results of a prospective, multicenter study;Charlton;Liver Transpl,2014

4. Sofosbuvir compassionate use program for patients with severe recurrent hepatits C including fibrosing cholestatic hepatitis following liver transplantation;Forns;Liver Transpl,2014

5. Long term outcome of mild hepatitis C recurrence after liver transplantation: a large prospective study;Gambato;Liver Transpl,2014